North America Opioid Use Disorder Market Thumbnail Image

2023

North America Opioid Use Disorder Market

North America Opioid Use Disorder Market, by Drug Type (Agonist, Antagonist), by Age group (19 to 39, 40 to 59, Age 60 and over), by Route of Administration (Oral, Intravenous, Sublingual), by Distribution channal (Hospital pharmacy, Retail Pharmacy): Opportunity Analysis and Industry Forecast, 2021-2031

LS : Pharmaceuticals

Select an option
Author's: Linu Dash | Roshan Deshmukh
Publish Date:

Get Sample to Email

The North America opioid use disorder market report presents the current market analysis along with a seven-year market forecast. The report offers an extensive study of the North America opioid use disorder market with detailed analysis of the significant factors affecting the market. The factors studied in the report include market dynamics, key segments, major countries, leading players, and competitive scenario.

Report Includes:

  • 80+ data tables and self-explanatory graphs

  • An overview of the regional market for North America opioid use disorder market

  • Analysis of market trends with data from 2020, estimates for 2021, and estimations of compound annual growth rates (CAGRs) through 2028

  • Discussion of drivers, opportunities, and restraints

North America Opioid Use Disorder Market, by Drug Type
By Drug Type
Your browser does not support the canvas element.

Agonist segment would witness the fastest growth, registering a CAGR of 11% during the forecast period.

The report offers size and forecast by analyzing the North America opioid use disorder market with diverse segments classified on the basis of drug type, age group, route of administration, distribution channal. Furthermore, it also includes the country-wise market analysis of these segments. Each segment is researched at the regional as well as country levels to gain a comprehensive understanding of the North America opioid use disorder market.

The competitive scenario of the global North America opioid use disorder market is discussed in the report, providing detailed analysis on competitive landscape. The key players operating in the global North America opioid use disorder market are studied to acknowledge their share, position, and competitive strength in the market. Analysis of these major players is included in the report to assist in providing a detailed understanding of these players in the market. Furthermore, the company profile section provides different data points, including brief company overview, key executives of the company, major growth strategies adopted by the company, recent financials, new initiatives or strategies adopted by company to sustain and enhance their position and share in the global North America opioid use disorder market, and with other competitors.

Key questions addressed by the report:

  • What are the major applications of the North America opioid use disorder market? How lucrative is the opportunity for their growth in the developing economies in the next seven years?

  • Which are the major companies in the North America opioid use disorder market? What are their key strategies to reinforce their market position?

  • What are the leading countries in the North America opioid use disorder market? What would be the share of each country in this market in the next seven years?

  • Where will all these developments in the North America opioid use disorder market take the industry in the mid to long term?

  • How will COVID-19 impact the North America opioid use disorder market?

North America Opioid Use Disorder Market, by Drug Type
By Age Group
Your browser does not support the canvas element.

19 to 39 segment Enterprises segment was the highest revenue contributor during the forecast period.

Research Methodology:

AMR offers its clients with a detailed study and research based on a broad variety of factual inputs, which mainly include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play a vital role in designing analytic tools and models, tailored as per the requirement of an industry segment.

For this research report, over 5,500 product type literatures, annual reports, industry releases, and other such documents of key industry participants have been studied for better market research. In addition, 20 hours of interviews have been conducted, with a wide range of professionals in the market, including upstream and downstream participants. Primary research is comprehensibly supported by extensive secondary research. Further, authentic industry journals, trade associations’ releases, and government websites have also been analyzed to obtain high-value industry insights.

COVID-19 Impact Analysis

The outbreak of the epidemic has led to a massive impact on the lives of people and the overall community. The report offers a brief overview of evolution of the coronavirus. Furthermore, it offers a macro and micro economic impact analysis on the market. The report further exhibits the market share and size based on the impact of the COVID-19. In addition, it offers an overview on the impact of COVID-19 on important aspects of the North America opioid use disorder market. On the other hand, the reduction in the number of COVID-infected patients, owing to the safety majors taken by governments such as imposition of lockdowns, stay-at-home policies, and provision of vaccines are expected to lower the impact of COVID-19 on the global North America opioid use disorder market. Additionally, the report also highlights the key strategies adopted by players to tackle the challenges created by the COVID-19 global health crisis. Along with this, the report provides an overview of pre- as well as post-COVID-19 impact analyses.

NORTH AMERICA OPIOID USE DISORDER MARKET REVENUE

Graph for representation purpose only

North America Opioid Use Disorder Market Report Highlights

Aspects Details
icon_5
By Drug Type
  • Agonist
    • Type
      • Methadone
      • Buprenorphine
  • Antagonist
icon_6
By Age group
  • 19 to 39
  • 40 to 59
  • Age 60 and over
icon_7
By Route of Administration
  • Oral
  • Intravenous
  • Sublingual
icon_8
By Distribution channal
  • Hospital pharmacy
  • Retail Pharmacy
icon_9
By Country
  • U.S.
  • Canada
  • Mexico
Author Name(s) : Linu Dash | Roshan Deshmukh

Loading Table Of Content...

North America Opioid Use Disorder Market

Opportunity Analysis and Industry Forecast, 2021-2031